Theoretical prediction of the relationship between phenol function and COX-2/AP-1 inhibition for ferulic acid-related compounds

In Vivo. 2005 Nov-Dec;19(6):1039-43.

Abstract

Ferulic acid-related compounds possess antioxidant activity. Dehydrodiisoeugenol and ferulic acid dimer (bis-FA), but not the parent monomers isoeugenol and ferulic acid, inhibit lipopolysaccharide (LPS)-induced cyclooxygenase-2 (COX-2) gene expression in RAW 264.7 cells. To clarify the mechanism of their inhibitory effects on COX-2 expression, the phenolic O-H bond dissociation enthalpy (BDE) and ionization potential (IP) of 8 ferulic acid-related compounds were calculated by both semi-empirical molecular orbital (AM1, PM3) and ab initio (3-21G* 6-31G*) and density function theory (DFT) (B3LYP) methods. COX-2 inhibition appeared in compounds with phenolic O-H BDE higher than 85.76 kcal/mol, as calculated by the density function theory (DFT) approach. The phenolic O-H BDEs of the most potent compounds, dehydrodiisoeugenol and bis-FA, were 85.99 and 85.76 kcal/mol, respectively. No causal relationship between COX-2 inhibition and IP was found. Neither dehydrodiisoeugenol nor bis-FA possessed significant scavenging activity against the 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical. The NSAID-like activity of dehydrodiisoeugenol and bis-FA appears to be related to their phenol function. Binding of activator protein-1 (AP-1) to the 12-tetradecanoylphorbol-13-acetate-responsive element (TRE) sequence in LPS-stimulated cells was inhibited by bis-FA at 1 microM and dehydrodiisoeugenol at 0.1 microM, but not by the parent monomers isoeugenol and ferulic acid.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology
  • Antioxidants / pharmacology*
  • Biphenyl Compounds / pharmacology
  • Bridged Bicyclo Compounds, Heterocyclic / chemistry
  • Bridged Bicyclo Compounds, Heterocyclic / pharmacology
  • Cell Line
  • Coumaric Acids / chemistry
  • Coumaric Acids / pharmacology*
  • Cyclooxygenase 2 Inhibitors / metabolism*
  • Dimerization
  • Electrophoretic Mobility Shift Assay
  • Eugenol / analogs & derivatives*
  • Eugenol / chemistry*
  • Eugenol / pharmacology*
  • Free Radical Scavengers / pharmacology
  • Gene Expression Regulation / drug effects
  • Guaiacol / analogs & derivatives
  • Guaiacol / chemistry
  • Guaiacol / pharmacology
  • Hydrazines / pharmacology
  • Lipopolysaccharides / pharmacology
  • Macrophages / drug effects
  • Macrophages / enzymology*
  • Mice
  • Models, Chemical
  • Models, Theoretical
  • Phenol / chemistry*
  • Picrates
  • Structure-Activity Relationship
  • Tetradecanoylphorbol Acetate / chemistry
  • Tetradecanoylphorbol Acetate / metabolism
  • Thermodynamics
  • Transcription Factor AP-1 / antagonists & inhibitors*
  • Transcription Factor AP-1 / metabolism

Substances

  • 4,8-bis(4-hydroxy-3-methoxyphenyl)-3,7-dioxabicyclo(3.3.0)octane-2,6-dione
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antioxidants
  • Biphenyl Compounds
  • Bridged Bicyclo Compounds, Heterocyclic
  • Coumaric Acids
  • Cyclooxygenase 2 Inhibitors
  • Free Radical Scavengers
  • Hydrazines
  • Lipopolysaccharides
  • Picrates
  • Transcription Factor AP-1
  • dehydrodiisoeugenol
  • Phenol
  • Eugenol
  • isoeugenol
  • Guaiacol
  • ferulic acid
  • 1,1-diphenyl-2-picrylhydrazyl
  • Tetradecanoylphorbol Acetate